Alpha 2.0
Login Register
» Articles » PMID: 26946464

STAT Order: Should Patients with Chronic Liver Disease Be Prescribed Statins to Prevent Fibrosis Progression and Hepatocellular Carcinoma?

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2016 Mar 7
PMID 26946464
Citations 4
Authors
Juan G Abraldes
Kelly W Burak
Affiliations
Soon will be listed here.
Citing Articles

Statins Show Promise Against Progression of Liver Disease.

Francis P, Forman L Clin Liver Dis (Hoboken). 2022; 18(6):280-287.

PMID: 34976372 PMC: 8688902. DOI: 10.1002/cld.1143.

Coenzyme Q10 or Creatine Counteract Pravastatin-Induced Liver Redox Changes in Hypercholesterolemic Mice.

Marques A, Busanello E, de Oliveira D, Catharino R, Oliveira H, Vercesi A Front Pharmacol. 2018; 9:685.

PMID: 29997512 PMC: 6030358. DOI: 10.3389/fphar.2018.00685.

The Use of Statins in Patients With Chronic Liver Disease and Cirrhosis.

Moctezuma-Velazquez C, Abraldes J, Montano-Loza A Curr Treat Options Gastroenterol. 2018; 16(2):226-240.

PMID: 29572618 DOI: 10.1007/s11938-018-0180-4.

Pleiotropic effects of statins in the diseases of the liver.

Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P World J Gastroenterol. 2016; 22(27):6201-13.

PMID: 27468210 PMC: 4945979. DOI: 10.3748/wjg.v22.i27.6201.